Frazier Life Sciences Acquisition Corp. II
FLSC- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002153598
In the last 90 days, Frazier Life Sciences Acquisition Corp. II insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
No financial statements
Frazier Life Sciences Acquisition Corp. II has no financial statements on Livermore. They come from the XBRL data in 10-K, 10-Q, 20-F and 40-F filings, so ETFs, funds and companies that don't file these reports have none.